146 related articles for article (PubMed ID: 37584829)
21. PIAS1 is a GATA4 SUMO ligase that regulates GATA4-dependent intestinal promoters independent of SUMO ligase activity and GATA4 sumoylation.
Belaguli NS; Zhang M; Garcia AH; Berger DH
PLoS One; 2012; 7(4):e35717. PubMed ID: 22539995
[TBL] [Abstract][Full Text] [Related]
22. PIAS1 interacts with and represses SOX9 transactivation activity.
Oh HJ; Kido T; Lau YF
Mol Reprod Dev; 2007 Nov; 74(11):1446-55. PubMed ID: 17440973
[TBL] [Abstract][Full Text] [Related]
23. Hypermethylation of miR-181b in monocytes is associated with coronary artery disease and promotes M1 polarized phenotype via PIAS1-KLF4 axis.
Wang Z; Li C; Sun X; Li Z; Li J; Wang L; Sun Y
Cardiovasc Diagn Ther; 2020 Aug; 10(4):738-751. PubMed ID: 32968630
[TBL] [Abstract][Full Text] [Related]
24. CREB SUMOylation by the E3 ligase PIAS1 enhances spatial memory.
Chen YC; Hsu WL; Ma YL; Tai DJ; Lee EH
J Neurosci; 2014 Jul; 34(29):9574-89. PubMed ID: 25031400
[TBL] [Abstract][Full Text] [Related]
25. PIAS1 alleviates diabetic peripheral neuropathy through SUMOlation of PPAR-γ and miR-124-induced downregulation of EZH2/STAT3.
Hou Z; Chen J; Yang H; Hu X; Yang F
Cell Death Discov; 2021 Dec; 7(1):372. PubMed ID: 34857740
[TBL] [Abstract][Full Text] [Related]
26. Hes-1 SUMOylation by protein inhibitor of activated STAT1 enhances the suppressing effect of Hes-1 on GADD45α expression to increase cell survival.
Chiou HY; Liu SY; Lin CH; Lee EH
J Biomed Sci; 2014 Jun; 21(1):53. PubMed ID: 24894488
[TBL] [Abstract][Full Text] [Related]
27. Protein inhibitor of activated STAT 1 (PIAS1) is identified as the SUMO E3 ligase of CCAAT/enhancer-binding protein β (C/EBPβ) during adipogenesis.
Liu Y; Zhang YD; Guo L; Huang HY; Zhu H; Huang JX; Liu Y; Zhou SR; Dang YJ; Li X; Tang QQ
Mol Cell Biol; 2013 Nov; 33(22):4606-17. PubMed ID: 24061474
[TBL] [Abstract][Full Text] [Related]
28. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
[TBL] [Abstract][Full Text] [Related]
29. Adipose-derived stem cell-derived microvesicle-released miR-210 promoted proliferation, migration and invasion of endothelial cells by regulating RUNX3.
Zheng Z; Liu L; Zhan Y; Yu S; Kang T
Cell Cycle; 2018; 17(8):1026-1033. PubMed ID: 29912616
[TBL] [Abstract][Full Text] [Related]
30. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification.
Tallec LP; Kirsh O; Lecomte MC; Viengchareun S; Zennaro MC; Dejean A; Lombès M
Mol Endocrinol; 2003 Dec; 17(12):2529-42. PubMed ID: 14500761
[TBL] [Abstract][Full Text] [Related]
31. CDKN2A deregulation in fatty liver disease and its accelerative role in the process of lipogenesis.
Zhang Z; Wen H; Peng B; Weng J; Zeng F
FASEB J; 2021 Apr; 35(4):e21230. PubMed ID: 33769609
[TBL] [Abstract][Full Text] [Related]
32. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
[TBL] [Abstract][Full Text] [Related]
33. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
[TBL] [Abstract][Full Text] [Related]
34. Far-infrared protects vascular endothelial cells from advanced glycation end products-induced injury via PLZF-mediated autophagy in diabetic mice.
Chen CH; Chen TH; Wu MY; Chou TC; Chen JR; Wei MJ; Lee SL; Hong LY; Zheng CM; Chiu IJ; Lin YF; Hsu CM; Hsu YH
Sci Rep; 2017 Jan; 7():40442. PubMed ID: 28071754
[TBL] [Abstract][Full Text] [Related]
35. SUMOylation of PCNA by PIAS1 and PIAS4 promotes template switch in the chicken and human B cell lines.
Mohiuddin M; Evans TJ; Rahman MM; Keka IS; Tsuda M; Sasanuma H; Takeda S
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12793-12798. PubMed ID: 30487218
[TBL] [Abstract][Full Text] [Related]
36. Potentiation of Tbx5-mediated transactivation by SUMO conjugation and protein inhibitor of activated STAT 1 (PIAS1).
Beketaev I; Kim EY; Zhang Y; Yu W; Qian L; Wang J
Int J Biochem Cell Biol; 2014 May; 50():82-92. PubMed ID: 24582888
[TBL] [Abstract][Full Text] [Related]
37. Thrombospondin-1 is a putative target gene of Runx2 and Runx3.
Shi X; Deepak V; Wang L; Ba X; Komori T; Zeng X; Liu W
Int J Mol Sci; 2013 Jul; 14(7):14321-32. PubMed ID: 23846726
[TBL] [Abstract][Full Text] [Related]
38. Alagebrium targets the miR-27b/TSP-1 signaling pathway to rescue N
Chen Y; Niu W; Chao YC; He Z; Ding R; Wu F; Liang C
Am J Transl Res; 2019; 11(3):1569-1580. PubMed ID: 30972183
[TBL] [Abstract][Full Text] [Related]
39. Leukemogenic kinase FIP1L1-PDGFRA and a small ubiquitin-like modifier E3 ligase, PIAS1, form a positive cross-talk through their enzymatic activities.
Ibata M; Iwasaki J; Fujioka Y; Nakagawa K; Darmanin S; Onozawa M; Hashimoto D; Ohba Y; Hatakeyama S; Teshima T; Kondo T
Cancer Sci; 2017 Feb; 108(2):200-207. PubMed ID: 27960034
[TBL] [Abstract][Full Text] [Related]
40. circRNA‑0006896‑miR1264‑DNMT1 axis plays an important role in carotid plaque destabilization by regulating the behavior of endothelial cells in atherosclerosis.
Wen Y; Chun Y; Lian ZQ; Yong ZW; Lan YM; Huan L; Xi CY; Juan LS; Qing ZW; Jia C; Ji ZH
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33649864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
